Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Auditory Circuits for Interpreting Vocal Communication Signals
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU
University of Pittsburgh as the GUDMAP Tissue Hub and Collection Site
Crystal Structure of Mtcp 1, an Oncogene Expressed in T Cell Malignancies
NSF Minority Postdoctoral Fellowship for FY 2009
Recently added grants:
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
Overcoming resistance to anti-PD1 immunotherapy
UFM1 signaling in DNA damage response and cancer therapy
Senescent Stroma Stimulates Inflammation to Promote Tumorigenesis
Quantitative Sciences Summer Undergraduate Research Experience (QSURE) Fellowship
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-005
Application #
7329501
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant